Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro, Emanuel Della‐Torre, Marco Ripa, Diana Canetti, Chiara Oltolini, Barbara Castiglioni, Chiara Tassan Din, Nicola Boffini, Alessandro Tomelleri, Nicola Farina, Annalisa Ruggeri, Patrizia Rovere‐Querini, Giuseppe Di Lucca, Sabina Martinenghi, Raffaella Scotti, Moreno Tresoldi, Fabio Ciceri, Giovanni Landoni, Alberto Zangrillo, Paolo Scarpellini, Lorenzo Dagna
Topics & Concepts
MedicineAnakinraRetrospective cohort studyPopulationHydroxychloroquineARDSInternal medicineMechanical ventilationCoronavirus disease 2019 (COVID-19)DiseaseLungInfectious disease (medical specialty)Environmental healthCOVID-19 Clinical Research StudiesRespiratory Support and MechanismsAdrenal Hormones and Disorders